New report recommends physicians carefully watch when a patient is on both an anticoagulant and an antiplatelet.
Potent P2Y12 inhibition plus direct oral anticoagulation did not cut ischemic risk and raised bleeding risk vs. clopidogrel ...
Abu Dhabi, UAE — The long-standing debate as to when to start anticoagulation in patients with an acute ischemic stroke and atrial fibrillation (AF) looks as though it’s settled. Results of the ...
In a recent study published in JAMA Network Open, researchers compared outcomes related to three direct oral anticoagulant (DOAC) care models to prevent anticoagulation-associated adverse effects ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Among patients hospitalized with atrial fibrillation who ...
People with valvular atrial fibrillation (AF) who are new users of direct oral anticoagulants (DOACs) experienced lower risks for ischemic stroke, systemic embolism (SE), and major bleeding compared ...
In older patients with atrial fibrillation (AF), apixaban seems to improve outcomes relative to warfarin regardless of frailty status, whereas other direct oral anticoagulants (DOACs) appear ...
Most recently, French investigators developed and internally validated a risk score in a population of people 80 years and older with a heavy burden of comorbidities who were taking the DOAC ...
In a departure from other transcatheter aortic valve replacement (TAVR, or TAVI) trials, direct oral anticoagulant (DOAC, or NOAC) therapy seemed to safely prevent subclinical leaflet thrombosis in ...
Among patients hospitalized for atrial fibrillation (AF) or flutter, prescription of an off-label dose of a direct oral anticoagulant (DOAC) at discharge remains relatively common, according to data ...
The direct oral anticoagulants edoxaban, apixaban, rivaroxaban and dabigatran have been recently approved for the treatment of non-valvular atrial fibrillation The new direct oral anticoagulants ...